| Symbol | CERS |
|---|---|
| Name | CERUS CORP |
| Sector | TECHNOLOGY |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 1220 CONCORD AVENUE, CONCORD, CA 94520 |
| Telephone | 9252886000 |
| Fax | — |
| — | |
| Website | https://www.cerus.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001020214 |
| Description | Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same. Additional info from NASDAQ: |
Cerus Corporation - Cerus Corporation Announces Second Quarter 2026 Financial Results
Read moreNew Form S-8 - CERUS CORP <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001193125-26-326371 <b>Size:</b> 213 KB
Read moreJayaraman Vivek K 🔴 sold 16.7K shares of CERUS CORP (CERS) at $3.16 Transaction Date: Jul 16, 2026 | Filing ID: 309044
Read more📋 VIVEK K JAYARAMAN (Officer) plans to sell 17K shares of CERUS CORPORATION (at $3.16 each, total $53K) Filed: Jul 16, 2026 | ID: 007149
Read moreCerus Corporation - Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
Read moreCerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
Read moreGreen Kevin Dennis 🔴 sold 97.3K shares of CERUS CORP (CERS) at $2.94 Transaction Date: Jun 30, 2026 | Filing ID: 000011
Read moreJayaraman Vivek K 🟡 adjusted position in 801.9K shares (1 derivative) of CERUS CORP (CERS) at $2.94 Transaction Date: Jun 30, 2026 | Filing ID: 000008
Read more